AU2001286232A1 - Process for producing paroxetine salt containing substantially no organic solvent - Google Patents

Process for producing paroxetine salt containing substantially no organic solvent

Info

Publication number
AU2001286232A1
AU2001286232A1 AU2001286232A AU8623201A AU2001286232A1 AU 2001286232 A1 AU2001286232 A1 AU 2001286232A1 AU 2001286232 A AU2001286232 A AU 2001286232A AU 8623201 A AU8623201 A AU 8623201A AU 2001286232 A1 AU2001286232 A1 AU 2001286232A1
Authority
AU
Australia
Prior art keywords
organic solvent
salt containing
containing substantially
paroxetine salt
producing paroxetine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286232A
Inventor
Erika Saito
Naoya Shimokawa
Shu-Zhong Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGC Inc
Original Assignee
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Glass Co Ltd filed Critical Asahi Glass Co Ltd
Publication of AU2001286232A1 publication Critical patent/AU2001286232A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001286232A 2000-09-14 2001-09-13 Process for producing paroxetine salt containing substantially no organic solvent Abandoned AU2001286232A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-280037 2000-09-14
JP2000280037 2000-09-14
PCT/JP2001/007967 WO2002022609A1 (en) 2000-09-14 2001-09-13 Process for producing paroxetine salt containing substantially no organic solvent

Publications (1)

Publication Number Publication Date
AU2001286232A1 true AU2001286232A1 (en) 2002-03-26

Family

ID=18764944

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286232A Abandoned AU2001286232A1 (en) 2000-09-14 2001-09-13 Process for producing paroxetine salt containing substantially no organic solvent

Country Status (4)

Country Link
US (1) US20030158416A1 (en)
JP (1) JPWO2002022609A1 (en)
AU (1) AU2001286232A1 (en)
WO (1) WO2002022609A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002085360A1 (en) * 2001-04-25 2002-10-31 Pentech Pharmaceuticals, Inc. Optimized procedures for the manufacture of paroxetine salts
WO2008004530A1 (en) * 2006-07-03 2008-01-10 Kyowa Hakko Bio Co., Ltd. Powder of hyaluronic acid or salt thereof, and method for producing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR001982A1 (en) * 1995-02-06 1998-01-07 Smithkline Beecham Plc PAROXETINE CHLORHYDRATE ANHYDRATED, AND PROCEDURE FOR ITS PREPARATION
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
AU3108097A (en) * 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
GB9828779D0 (en) * 1998-12-29 1999-02-17 Smithkline Beecham Plc Novel process

Also Published As

Publication number Publication date
JPWO2002022609A1 (en) 2004-01-22
WO2002022609A1 (en) 2002-03-21
US20030158416A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
AU2002337722A1 (en) Process for preparing pentacene derivatives
AU775075C (en) Method for separating analogous organic compounds
AU2003261774A1 (en) PROCESS FOR PRODUCING L-Alpha-METHYLCYSTEINE DERIVATIVE
AU2911300A (en) Method for producing compounded acetonitrile derivatives
AU5884700A (en) Process for making amine compounds
HUP0100921A3 (en) Process for producing organic sylile alkyl polysulphanes
AU2002218171A1 (en) Method for producing aryl compounds
AU7040700A (en) Process for preparing sulfoxide compounds
AU2416700A (en) Process for producing organic polysulfides
AU2001295934A2 (en) Process for producing substituted aniline compound
AU2001295934A1 (en) Process for producing substituted aniline compound
AU2002228008A1 (en) Process for preparing fluorinated organic compounds
AU2001286232A1 (en) Process for producing paroxetine salt containing substantially no organic solvent
AU2002222604A1 (en) Process for preparing substance GM-95
AU2001281790A1 (en) Method for formulating organic compounds
HUP0000366A3 (en) Process for producing heterocyclic compounds
HU0000740D0 (en) Process for producing organic azides
AU6598200A (en) Process for producing oxirane compound
AU2001280244A1 (en) Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine
HUP0203878A3 (en) Method for producing heterocyclic compounds
AU7105800A (en) Process for synthesizing isoxazolidines
AU5135600A (en) Process for producing piperidine
AU2003240491A1 (en) Process for preparing vinylaromatic compounds
AU2001235423A1 (en) Method for producing 2,3,5,6-tetrahalogen-xylylidene compounds
AU2001284442A1 (en) Process for producing fluoroalkanol